The idea that information has value both as a business tool and as a means to contribute to social good defines The Rise ...
As we enter the final quarter of 2025, the fixed income landscape is shaped by slowing economic growth and the Federal ...
Below is an interview with six senior living executives who will be speaking at the 2025 BUILD-BRAIN conference in Dallas, Texas. Hear more ...
Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...
From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, and Protalix BioTherapeutics, Inc.
Study in healthy adults: two common processed fats delivered similar cholesterol, inflammation, and vessel-function results ...
On Friday 17th October, the European Society for Medical Oncology’s Annual Meeting 2025 kicked off, with the opening press ...
The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback